Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

731 - 740 of 1307 results found

Luteolin is a potential inhibitor of COVID-19: An in silico analysis

Date
Monday, September 25, 2023 - 4:00 AM
Description
The severe respiratory syndrome 2019 novel coronavirus disease (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread explosively, raising global health concerns. Luteolin shows antiviral properties, but its